William Blair Starts Rhythm Pharmaceuticals (RYTM) at Outperform
October 16, 2026 3:11 AM
William Blair analyst Alethia Young initiates coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Outperform rating.The analyst comments: “We are ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
